Cargando…
Effectiveness of combination therapy with ISA101 vaccine for the treatment of human papillomavirus-induced cervical cancer
Cervical cancer is one of the women-associated tumors that affects numerous people yearly. It is the fourth most common malignancy in women worldwide. Following early diagnosis, this cancer can be cured mainly by traditional methods such as surgery, tumor resection, and chemotherapy; nonetheless, it...
Autores principales: | Ding, Haigang, Zhang, Juan, Zhang, Feng, Xu, Yan, Yu, Yijun, Liang, Wenqing, Li, Qingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589033/ https://www.ncbi.nlm.nih.gov/pubmed/36300095 http://dx.doi.org/10.3389/fonc.2022.990877 |
Ejemplares similares
-
Comparative study on the immunopotentiator effect of ISA 201, ISA 61, ISA 50, ISA 206 used in trivalent foot and mouth disease vaccine
por: Ibrahim, Ehab El-Sayed, et al.
Publicado: (2015) -
ISA101 and nivolumab for HPV-16(+) cancer: updated clinical efficacy and immune correlates of response
por: de Sousa, Luana Guimaraes, et al.
Publicado: (2022) -
Nanotechnological approaches for diagnosis and treatment of ovarian cancer: a review of recent trends
por: Ding, Haigang, et al.
Publicado: (2022) -
Awareness of Cervical Cancer and Attitude Toward Human Papillomavirus and Its Vaccine Among Ghanaians
por: Drokow, Emmanuel Kwateng, et al.
Publicado: (2020) -
Cervical Cancer Awareness and Attitude Towards Cervical Cancer Screening and Human Papillomavirus Vaccines Among Urban Women of Karachi, Pakistan
por: Shahnaz, Saira, et al.
Publicado: (2023)